Elevated levels of IL-22 in AD patients are associated with increased keratinocyte proliferation, modifications in skin microbiota, and compromised epidermal barrier function, all of which contribute to the hallmark symptoms of AD. The gene discussed is IL22; the disease is Alzheimer disease.